AnalystsMadhu KumarMadhu Kumar's Stock Forecasts
AnalystsMadhu Kumar
Analyst Ranking
Top 2%
#61 out of 4051 analysts
Average Return
+26.76%
Win Rate
54%36 out of 67
Risk vs Reward
Poor
Good
Madhu Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Catalyst Biosciences IncCBIO | +450.00% | $4.38 | $24.09 | 2017-06-12 - 2018-06-12 | Strong Buy |
Scholar Rock Holding CorpSRRK | +331.26% | $14.97 | $64.56 | 2020-03-12 - 2021-03-12 | Buy |
Arbutus Biopharma CorpABUS | +309.92% | $1.21 | $4.96 | 2020-03-27 - 2020-07-24 | Buy |
Clementia Pharmaceuticals IncCMTA | +211.47% | $8.46 | $26.35 | 2018-08-15 - 2019-04-17 | Strong Buy |
Arcturus Therapeutics Holdings IncARCT | +206.96% | $13.80 | $42.36 | 2020-02-11 - 2020-12-29 | Buy |
Madhu Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Jazz Pharmaceuticals PLCJAZZ | 3 | Hold | $170.00 | +24.64% | Maintains | 7 days ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $28.00 | -6.13% | Maintains | 15 days ago |
Homology Medicines IncFIXX | 1 | Buy | $9.00 | +500.00% | Maintains | a month ago |
Krystal Biotech IncKRYS | 2 | Hold | $74.00 | +5.97% | Downgrades | a month ago |
Edgewise Therapeutics IncEWTX | 2 | Strong Sell | $5.00 | -53.10% | Downgrades | a month ago |
Magenta Therapeutics IncMGTA | 2 | Hold | $2.00 | +49.25% | Downgrades | a month ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $35.00 | +41.53% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 6 | Strong Buy | $102.00 | +76.81% | Maintains | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 6 | Strong Buy | $65.00 | +88.62% | Maintains | 2 months ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Strong Buy | $144.00 | +114.77% | Maintains | 2 months ago |
Myovant Sciences LtdMYOV | 1 | Hold | $10.00 | -59.89% | Maintains | 2 months ago |
Iovance Biotherapeutics IncIOVA | 3 | Strong Buy | $18.00 | +82.74% | Maintains | 3 months ago |
Reata Pharmaceuticals IncRETA | 2 | Strong Buy | $73.00 | +197.59% | Maintains | 4 months ago |
Tricida IncTCDA | 1 | Strong Buy | $25.00 | +119.30% | Initiates Coverage On | 6 months ago |
Alector IncALEC | 1 | Strong Sell | $9.00 | -2.60% | Initiates Coverage On | 6 months ago |
Passage Bio IncPASG | 1 | Hold | $6.00 | +354.55% | Downgrades | 9 months ago |
Design Therapeutics IncDSGN | 1 | Strong Sell | $10.00 | -40.37% | Initiates Coverage On | 9 months ago |
Arvinas IncARVN | 1 | Strong Buy | $157.00 | +250.60% | Initiates Coverage On | 9 months ago |
Applied Therapeutics IncAPLT | 1 | Strong Sell | $10.00 | N/A | Downgrades | a year ago |
Dicerna Pharmaceuticals IncDRNA | 5 | Hold | $25.00 | N/A | Downgrades | a year ago |
Arcturus Therapeutics Holdings IncARCT | 3 | Strong Sell | $29.00 | N/A | Downgrades | a year ago |
Dynavax Technologies CorpDVAX | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | a year ago |
Intellia Therapeutics IncNTLA | 5 | Hold | $85.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 3 | Strong Sell | $20.00 | N/A | Initiates Coverage On | a year ago |
Cellectis SaCLLS | 2 | Buy | $39.00 | N/A | Upgrades | 2 years ago |
Gritstone Bio IncGRTS | 1 | Sell | $8.00 | N/A | Downgrades | 2 years ago |
Cellular Biomedicine Group IncCBMG | 2 | Hold | $19.00 | N/A | Downgrades | 2 years ago |
Uniqure NvQURE | 2 | Buy | $57.00 | N/A | Upgrades | 2 years ago |
Arbutus Biopharma CorpABUS | 8 | Hold | N/A | N/A | Downgrades | 2 years ago |
Aprea Therapeutics IncAPRE | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Vir Biotechnology IncVIR | 1 | Sell | $20.00 | N/A | Maintains | 3 years ago |
Pieris Pharmaceuticals IncPIRS | 1 | Buy | $5.00 | N/A | Upgrades | 3 years ago |
Scholar Rock Holding CorpSRRK | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Leap Therapeutics IncLPTX | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Spark Therapeutics IncONCE | 1 | Strong Buy | $71.00 | N/A | Upgrades | 4 years ago |
Eyepoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $6.00 | N/A | Maintains | 4 years ago |
Assembly Biosciences IncASMB | 3 | Strong Buy | $42.00 | N/A | Upgrades | 4 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $55.00 | N/A | Maintains | 4 years ago |
Clementia Pharmaceuticals IncCMTA | 2 | Strong Buy | $16.00 | N/A | Maintains | 4 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $230.00 | N/A | Maintains | 4 years ago |
Regulus Therapeutics IncRGLS | 3 | Hold | $0.50 | N/A | Maintains | 4 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Catalyst Biosciences IncCBIO | 2 | Strong Buy | $75.00 | N/A | Maintains | 5 years ago |
Inflarx NvIFRX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Akari Therapeutics PLCAKTX | 3 | Hold | $3.00 | N/A | Initiates Coverage On | 5 years ago |
Achillion Pharmaceuticals IncACHN | 1 | Hold | $3.50 | N/A | Initiates Coverage On | 5 years ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $21.50 | N/A | Reinstates | 5 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $23.50 | N/A | Initiates Coverage On | 6 years ago |
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.